Skip to main content

Clinical Trial for New Corona Virus Approved for Hydroxychloroquine in US


Hydroxychloroquine clinical trial for new coronary pneumonia approved in the US by the US-FDA

According to a recent report from the US Newsweek website, Novartis Pharmaceuticals, headquartered in Switzerland, said it has reached an agreement with the US Food and Drug Administration to launch a new anti-malarial drug hydroxychloroquine treatment in the United States Clinical trials of hospitalized patients with pneumonia. The entire trial involved 400 patients to assess the effectiveness of the drug.

According to the US Centers for Disease Control and Prevention, there are currently no effective therapies and vaccines that can cure new coronary pneumonia.

In recent weeks, a number of clinical tests have been conducted around the world to determine whether hydroxychloroquine can relieve some symptoms of new coronary pneumonia, but the results obtained are very different.

US President Donald Trump previously said in a White House briefing and Twitter that the drug has potential therapeutic effects, and that the United States has stored 29 million hydroxychloroquine, but this has not been confirmed.

Drugs used in Coronavirus trial

Novartis said that clinical trials will be carried out in "a dozen places" in the United States, and volunteer recruitment will begin in the next few weeks. The drugs used in the trials will be provided by the company's generic and biosimilars departments.

Trials Approved by USFDA Simulation for Hydroxychloroquine in US for COVID-19

It is reported that in this trial, patients will be randomly divided into three groups: the first group taking hydroxychloroquine; the second group taking hydroxychloroquine combined with azithromycin (an antibiotic).

Is hydroxychloroquine beneficial to COVID-19 patients?

The third group taking placebo drugs. John Chua, Chief Medical Officer of Novartis, said:
"It is very important to answer the scientific question of whether hydroxychloroquine is beneficial to patients with new coronary pneumonia. We hope this randomized, placebo-controlled study can solve this problem."

Novartis plans co-sponsor clinical trials

It is reported that in addition to hydroxychloroquine, Novartis also plans to sponsor or co-sponsor clinical trials to study the efficacy of kinase inhibitors lucotinib and canastuzumab in the treatment of inpatients with new coronary pneumonia.



 

Author's Bio

Doctor Shawna Reason, Virologist
Dr. Shawna Reason
Name: Shawna Reason

Education: MBBS, MD

Occupation: Medical Doctor / Virologist 

Specialization: Medical Science, Micro Biology / Virology, Natural Treatment

Experience: 15 Years as a Medical Practitioner

About Me | Linkedin | Quora Profile | Medium Profile | Twitter



Labels:

Comments

Post a Comment

Popular posts from this blog

10 Methods to Regulate High Blood Pressure without Medication

By implementing these 10 lifestyle changes, you can lower your blood pressure and heart disease risk. If you have been given a high blood pressure diagnosis, you might be concerned about taking medication to lower your reading.   Your approach to managing high blood pressure is crucial. If you successfully manage your blood pressure, you can avoid, delay, or reduce the need for medication with healthy lifestyle choices.   There are several lifestyle changes you may make to lower and maintain your blood pressure. Table Of Contents 1. Reduce your weight further and examine your waistline Blood pressure frequently rises as weight increases. Sleep apnea, which can be brought on by being overweight, causes breathing disturbances while you sleep and raises your blood pressure.   Losing weight is one of the most productive lifestyle changes for controlling blood pressure. If you are overweight or obese, even a small weight loss can help lo...
1 comment
Read more

Fish Disease, Symptoms and Control

  19 common Fish Diseases and their Symptoms and Control In the late 1980s, Penaeus vannamei was imported from South America to my nation. In aquaculture, the term "fish health management" refers to a management strategy intended to stop fish infections. Fish that grow sick can be challenging to save. Instead of beginning with therapy, good fish health care starts with prevention. The right water quality, diet, and sanitation practises are necessary for the prevention of fish infections. Opportunistic disease epidemics cannot be stopped without this basis. Fish are routinely cleaned with potentially harmful bacteria, fungus, and viruses. Even the use of sterilisation technology (such as ozonation and ultraviolet sterilisers) cannot completely rid the environment of possible microorganisms. These bacteria can become infected when there are stressful circumstances present as well as poor water quality, inadequate diet, or a depressed immune system. The medications used to tre...
Post a Comment
Read more